{"id":279850,"date":"2026-09-30T10:25:16","date_gmt":"2026-09-30T04:55:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=279850"},"modified":"2026-10-16T10:01:47","modified_gmt":"2026-10-16T04:31:47","slug":"why-mankind-pharma-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/","title":{"rendered":"Mankind Pharma (MANKIND) Share Price Falls 2.12% in Early Trade"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma (MANKIND)<\/a> share price fell to Rs 2,304.95 today, down 2.12% from the previous close. Market cap was Rs 96,243.64 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Mankind Share Price is trading at Rs 2,304.95, down 2.12% from the previous close, with Mankind Pharma valued at Rs 96,243.64 Cr in a Large Cap frame. The move keeps Mankind Share Price in focus for investors tracking Mankind Share Price Today, Mankind Stock News and Mankind Share Price Fall along with the company\u2019s healthcare positioning.For readers following Univest coverage, the key task now is to separate the day\u2019s price action from the company\u2019s financial profile, sector comparison and peer valuation backdrop. Mankind Share Price therefore matters not only for the decline itself, but also for how the stock sits versus healthcare benchmarks on profit quality and valuation ratios.<\/p>\n<p>Mankind Share Price also matters because the company is a Large Cap pharmaceutical name, and even a modest percentage move can change how the market reads the stock\u2019s short-term positioning. Univest tracks such moves alongside Mankind Share Price Live, Mankind Share Price Update and Mankind Stock Analysis so investors can place the fall in a broader context without assuming a cause that is not verified.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Mankind_Pharma_MANKIND_Share_Price_Today_Price_Action_Analysis\" title=\"Mankind Pharma (MANKIND) Share Price Today: Price Action Analysis\">Mankind Pharma (MANKIND) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Why_Mankind_Pharma_MANKIND_May_Be_Moving_Today\" title=\"Why Mankind Pharma (MANKIND) May Be Moving Today\">Why Mankind Pharma (MANKIND) May Be Moving Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Mankind_Pharma_MANKIND_Fundamental_Analysis\" title=\"Mankind Pharma (MANKIND) Fundamental Analysis\">Mankind Pharma (MANKIND) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Mankind_Pharma\" title=\"Why Investors Are Watching Mankind Pharma\">Why Investors Are Watching Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#About_Mankind_Pharma\" title=\"About Mankind Pharma\">About Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Track_Mankind_Share_Price_on_Univest\" title=\"Track Mankind Share Price on Univest\">Track Mankind Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Why_is_Mankind_Share_Price_falling_today\" title=\"Why is Mankind Share Price falling today?\">Why is Mankind Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#What_is_the_current_Mankind_Share_Price\" title=\"What is the current Mankind Share Price?\">What is the current Mankind Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#What_is_Mankind_Pharmas_market_capitalisation\" title=\"What is Mankind Pharma\u2019s market capitalisation?\">What is Mankind Pharma\u2019s market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#How_does_Mankind_Share_Price_compare_on_valuation\" title=\"How does Mankind Share Price compare on valuation?\">How does Mankind Share Price compare on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#What_do_ROE_and_ROCE_show_for_Mankind_Pharma\" title=\"What do ROE and ROCE show for Mankind Pharma?\">What do ROE and ROCE show for Mankind Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#What_is_the_book_value_and_EPS_for_Mankind_Share_Price\" title=\"What is the book value and EPS for Mankind Share Price?\">What is the book value and EPS for Mankind Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#How_does_Mankind_Share_Price_compare_with_healthcare_peers\" title=\"How does Mankind Share Price compare with healthcare peers?\">How does Mankind Share Price compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Is_Mankind_Share_Price_linked_to_any_reported_corporate_development\" title=\"Is Mankind Share Price linked to any reported corporate development?\">Is Mankind Share Price linked to any reported corporate development?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-price-fall-today-2026\/#Should_investors_track_Mankind_Share_Price_on_Univest\" title=\"Should investors track Mankind Share Price on Univest?\">Should investors track Mankind Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_MANKIND_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Mankind Pharma (MANKIND) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,304.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,354.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 49.85 (-2.12%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,354.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,355<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,301.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 96,243.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Share Price opened at Rs 2,354.60, touched a high of Rs 2,355.00 and a low of Rs 2,301.40, and was last traded at Rs 2,304.95. The current price is Rs 49.85 below the previous close of Rs 2,354.80, which works out to a 2.12% decline. That puts Mankind Share Price in the centre of today\u2019s stock performance discussion, especially because the move occurred within a tight intraday band rather than through a wide swing.<\/p>\n<p>With a market capitalisation of Rs 96,243.64 Cr, Mankind Pharma remains a Large Cap stock, so the day\u2019s decline is being viewed against a significant base. Mankind Share Price Today therefore shows a clear price fall, but the range also shows that the stock traded near its opening level before easing lower. For readers scanning Mankind Share Price Today, the factual takeaway is simple: the stock is weaker, the move is measurable, and the market cap keeps it firmly in the large-company bracket. The next layer is fundamentals, because Mankind Share Price is not moving in isolation from valuation and earnings metrics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Mankind_Pharma_MANKIND_May_Be_Moving_Today\"><\/span><strong>Why Mankind Pharma (MANKIND) May Be Moving Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"news-context\">According to recent news reports, Mankind Pharma&#8217;s board has approved an investment of up to \u20ac45 million in its Netherlands subsidiary. The company also plans to acquire a 70% stake in Armed Cell Therapeutics for \u20ac48 million. There is one reported item, and these strategic moves point to overseas expansion and a wider growth footprint. The market data itself does not establish a single confirmed cause for Mankind Share Price movement today, so the reported corporate action is best read as same-day context rather than a proven trigger.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_MANKIND_Fundamental_Analysis\"><\/span><strong>Mankind Pharma (MANKIND) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 96,243.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 49.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 407.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.04%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Pharma (MANKIND) fundamental metrics show P\/E 47.62x, P\/B 5.78x, ROE 12.69%, ROCE 13.24%. These ratios show where the company stands today and are not a call to buy or sell.<\/p>\n<p>Mankind Pharma has a market capitalisation of Rs 96,243.64 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 47.62x, P\/B at 5.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.08x, median ROE of 11.48%, median ROCE of 13.28%. Together they describe the fundamental backdrop without implying a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.65x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.33x to 640x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 96,243.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 806.56 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,634.43 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Pharma (MANKIND) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Mankind Pharma (MANKIND) has a P\/E ratio of 47.62x, which is above the benchmark median of 31.08x, a difference of +53.22%. A P\/E difference of this kind is a reference point rather than a recommendation.<\/p>\n<p>Mankind Pharma (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.48%, a difference of +10.54%. Mankind Pharma (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.28%, a difference of -0.3%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,19,619.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,39,714.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,74,740.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">80.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,119.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,007.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">99.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Pharma (MANKIND) has a P\/E ratio of 47.62x compared with the displayed peer median of 80.33x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma (MANKIND) has a market capitalisation of Rs 96,243.64 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Mankind_Pharma\"><\/span><strong>Why Investors Are Watching Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Mankind Share Price is down 2.12% today, so traders are watching whether the decline stays contained or extends further in the session.<\/li>\n<li>The current price of Rs 2,304.95 sits below the previous close of Rs 2,354.80, which keeps Mankind Share Price in active focus on Univest.<\/li>\n<li>Mankind Share Price carries a P\/E of 47.62 and a P\/B of 5.78, which makes valuation an important part of the discussion.<\/li>\n<li>ROE at 12.69% and ROCE at 13.24% give Mankind Share Price a return profile that investors can compare with healthcare peers.<\/li>\n<li>The stock belongs to the Healthcare sector and Pharmaceuticals &amp; Drugs industry, so sector benchmark comparison remains relevant for Mankind Share Price.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Mankind_Pharma\"><\/span><strong>About Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mankind Pharma operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company is part of the Large Cap universe by market capitalisation, with a market value of Rs 96,243.64 Cr. Mankind Share Price therefore reflects a business that sits among major listed pharmaceutical names in India. The company works in a segment where valuation, earnings quality and return ratios often influence how investors compare one name with another. For readers following Mankind Stock News, the business context is straightforward: this is a large healthcare company whose stock is assessed against both sector peers and broader pharma benchmarks. Mankind Share Price today is only one part of that larger company profile.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Mankind_Share_Price_on_Univest\"><\/span><strong>Track Mankind Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma (MANKIND) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Track Mankind Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights in one place. Univest also helps readers follow Mankind Share Price Today, Mankind Stock Analysis and Mankind Share Price Update alongside key company metrics. If you are reviewing Mankind Share Price after today\u2019s decline, the same page keeps the price action, valuation and sector context together for quick reference.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Mankind_Share_Price_falling_today\"><\/span><strong>Why is Mankind Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Mankind Share Price is down 2.12% at Rs 2,304.95 versus the previous close of Rs 2,354.80.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Mankind_Share_Price\"><\/span><strong>What is the current Mankind Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Mankind Share Price is trading at Rs 2,304.95. The stock moved between Rs 2,301.40 and Rs 2,355.00 during the day, keeping the decline contained within a relatively narrow intraday range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharmas_market_capitalisation\"><\/span><strong>What is Mankind Pharma\u2019s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Mankind Pharma has a market capitalisation of Rs 96,243.64 Cr and is categorised as a Large Cap stock. That size context is important when reading Mankind Share Price and its day-to-day movement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Mankind_Share_Price_compare_on_valuation\"><\/span><strong>How does Mankind Share Price compare on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Mankind Share Price has a P\/E ratio of 47.62 and a P\/B ratio of 5.78. Both metrics sit above the benchmark median for the pharmaceutical industry, which makes valuation part of the story.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Mankind_Pharma\"><\/span><strong>What do ROE and ROCE show for Mankind Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;ROE is 12.69% and ROCE is 13.24% for Mankind Pharma. Those return ratios are close to the industry benchmark, which gives Mankind Share Price a balanced operating context. The relevant peer median ROE is 11.48%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_book_value_and_EPS_for_Mankind_Share_Price\"><\/span><strong>What is the book value and EPS for Mankind Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;EPS stands at Rs 49.45 and book value is Rs 407.39. These per-share figures help explain the earnings base and accounting net worth behind Mankind Share Price. The previous close was Rs 2,354.8.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Mankind_Share_Price_compare_with_healthcare_peers\"><\/span><strong>How does Mankind Share Price compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Mankind Share Price trades above Zydus Lifesciences and Sun Pharma on P\/E, while Divi\u2019s Laboratories and Torrent Pharmaceuticals carry higher valuation multiples. The peer set gives useful context for comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Mankind_Share_Price_linked_to_any_reported_corporate_development\"><\/span><strong>Is Mankind Share Price linked to any reported corporate development?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;A news item reported an investment of up to \u20ac45 million in the Netherlands subsidiary and a planned 70% stake purchase in Armed Cell Therapeutics for \u20ac48 million.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Mankind_Share_Price_on_Univest\"><\/span><strong>Should investors track Mankind Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Yes, investors tracking Mankind Share Price can use Univest for live price, valuation ratios, peer comparison and sector context. That helps place today\u2019s decline alongside the company\u2019s broader financial profile.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Mankind Share Price falling today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mankind Share Price is down 2.12% at Rs 2,304.95 versus the previous close of Rs 2,354.80. The price move is confirmed in Univest data; a company-specific reason has not been established.\"}},{\"@type\":\"Question\",\"name\":\"What is the current Mankind Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mankind Share Price is trading at Rs 2,304.95. The stock moved between Rs 2,301.40 and Rs 2,355.00 during the day, keeping the decline contained within a relatively narrow intraday range.\"}},{\"@type\":\"Question\",\"name\":\"What is Mankind Pharma\u2019s market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mankind Pharma has a market capitalisation of Rs 96,243.64 Cr and is categorised as a Large Cap stock. That size context is important when reading Mankind Share Price and its day-to-day movement.\"}},{\"@type\":\"Question\",\"name\":\"How does Mankind Share Price compare on valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mankind Share Price has a P\/E ratio of 47.62 and a P\/B ratio of 5.78. Both metrics sit above the benchmark median for the pharmaceutical industry, which makes valuation part of the story.\"}},{\"@type\":\"Question\",\"name\":\"What do ROE and ROCE show for Mankind Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ROE is 12.69% and ROCE is 13.24% for Mankind Pharma. Those return ratios are close to the industry benchmark, which gives Mankind Share Price a balanced operating context. The relevant peer median ROE is 11.48%.\"}},{\"@type\":\"Question\",\"name\":\"What is the book value and EPS for Mankind Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"EPS stands at Rs 49.45 and book value is Rs 407.39. These per-share figures help explain the earnings base and accounting net worth behind Mankind Share Price. The previous close was Rs 2,354.8.\"}},{\"@type\":\"Question\",\"name\":\"How does Mankind Share Price compare with healthcare peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mankind Share Price trades above Zydus Lifesciences and Sun Pharma on P\/E, while Divi\u2019s Laboratories and Torrent Pharmaceuticals carry higher valuation multiples. The peer set gives useful context for comparison.\"}},{\"@type\":\"Question\",\"name\":\"Is Mankind Share Price linked to any reported corporate development?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A news item reported an investment of up to \u20ac45 million in the Netherlands subsidiary and a planned 70% stake purchase in Armed Cell Therapeutics for \u20ac48 million. The market data itself does not confirm a cause.\"}},{\"@type\":\"Question\",\"name\":\"Should investors track Mankind Share Price on Univest?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, investors tracking Mankind Share Price can use Univest for live price, valuation ratios, peer comparison and sector context. That helps place today\u2019s decline alongside the company\u2019s broader financial profile.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma Share Price fell 2.12% to Rs 2,304.95 today. Market cap stands at Rs 96,243.64 crore.<\/p>\n","protected":false},"author":35,"featured_media":312414,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-279850","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["312414"],"rank_math_title":["Mankind Share Price Falls 2.12% as Valuation Stands Out"],"rank_math_description":["Mankind Share Price fell 2.12% to Rs 2,304.95. See the price action, valuation ratios, healthcare sector comparison and peer context."],"rank_math_focus_keyword":["Mankind Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Mankind_Pharma_MANKIND_Share_Price_Falls_212_in_Early_Trade_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/279850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=279850"}],"version-history":[{"count":5,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/279850\/revisions"}],"predecessor-version":[{"id":312415,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/279850\/revisions\/312415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/312414"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=279850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=279850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=279850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}